22
Jul
2010
Genetic Susceptibility to Clinically Aggressive Prostate Cancer Project Leader: Janet Stanford, Ph.D. Co-leader: Daniel Lin, M.D. Of the estimated 168,811 men who will be treated for prostate cancer (PC) with curative intent in 2006, >30% will ultimately experience disease recurrence, metastasis, and die of PC. There is substantial uncertainty, however,
